Active, not recruitingNCT07554157
Development of a Pan-Cancer Screening Model Based on Blood Biomarkers
Studying Polyarteritis nodosa
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Zhejiang Cancer Hospital
- Principal Investigator
- Xiangdong Cheng, MD, PhDZhejiang Cancer Hospital
- Intervention
- No intervention(other)
- Enrollment
- 10000000 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2025 – 2030
Study locations (1)
- Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07554157 on ClinicalTrials.govOther trials for Polyarteritis nodosa
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07560943Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid TumorsWest China Hospital
- ACTIVE NOT RECRUITINGNCT07584044A Pan-Cancer Retrospective Study on the Relationship Between Tumor Microenvironment Composition and Efficacy of Antibody-Based Antitumor TherapyTianjin Medical University Cancer Institute and Hospital